0001243233-15-000003.txt : 20150126 0001243233-15-000003.hdr.sgml : 20150126 20150126134952 ACCESSION NUMBER: 0001243233-15-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150126 DATE AS OF CHANGE: 20150126 EFFECTIVENESS DATE: 20150126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LineaGen, Inc CENTRAL INDEX KEY: 0001415979 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-232853 FILM NUMBER: 15547921 BUSINESS ADDRESS: STREET 1: 423 Wakara Way STREET 2: SUITE 200 CITY: Salt Lake City STATE: UT ZIP: 84108 BUSINESS PHONE: 801-931-6200 MAIL ADDRESS: STREET 1: 423 Wakara Way STREET 2: SUITE 200 CITY: Salt Lake City STATE: UT ZIP: 84108 FORMER COMPANY: FORMER CONFORMED NAME: LineaGen Inc DATE OF NAME CHANGE: 20071024 D 1 primary_doc.xml X0707 D LIVE 0001415979 LineaGen, Inc 2677 E Parleys Way Salt Lake City UT UTAH 84109 801-931-6200 DELAWARE LineaGen Inc Corporation true Michael S. Paul c/o LineaGen, Inc. 2677 E Parleys Way Salt Lake City UT UTAH 84109 Executive Officer Director Stephen M. Prescott 7305 Waverly Ave. Nichols Hills OK OKLAHOMA 73120 Director Fred A. Middleton c/o Sanderling Venture Partners, VI, LP 400 S. El Camino Real, Suite 1200 San Mateo CA CALIFORNIA 94402 Director Lisa Dunlea c/o Signal Peak Ventures 2795 East Cottonwood Parkway, Suite 360 Salt Lake City UT UTAH 84121 Director Michael Walsh 4710 Plummer Court San Diego CA CALIFORNIA 92130 Director Michael Fitzgerald c/o Petra Growth Fund III, L.P. 3825 Bedford Avenue, Suite 101 Nashville TN TENNESSEE 37215 Director Mary C. Tanner c/o Evolution Life Science Partners 257 Park Avenue South, 15th Floor New York NY NEW YORK 10010 Director Gayland Moffat c/o LineaGen, Inc. 2677 E Parleys Way Salt Lake City UT UTAH 84109 Executive Officer David Kabakoff c/o Sofinnova HealthQuest Partners 3000 Sand Hill Road, Bldg 4 Ste 250 Menlo Park CA CALIFORNIA 94025 Director Other Health Care Decline to Disclose 06b false 2015-01-09 false true true Shares of Series C-1 Preferred Stock and the underlying shares of Common Stock issuable upon conversion thereof false 0 12173420 12173420 0 false 10 0 0 0 true false LineaGen, Inc /s/ Frederick Dorey Frederick Dorey Assistant Secretary 2015-01-26